Hydroxypropyl Beta-cyclodextrin (HP-β-CD) Has Achieved Breakthrough Progress in The Pharmaceutical And Food Industries.

Recent studies have shown that Hydroxypropyl Beta-Cyclodextrin (HP-β-CD), as a multifunctional carrier material, exhibits broad application prospects in pharmaceuticals, food, cosmetics, and other fields. The latest research indicates that HP-β-CD not only demonstrates significant anti-inflammatory effects in the treatment of ulcerative colitis but also achieves important breakthroughs in food preservation and drug delivery.

Pharmaceutical Field: New Strategy for Ulcerative Colitis Treatment

A research team from China Pharmaceutical University discovered that HP-β-CD and its derivative, Sulfobutyl Ether Beta-Cyclodextrin Sodium (SEB), can improve acute ulcerative colitis by inhibiting inflammatory factors (such as IL-6, TNF-α), protecting the intestinal barrier, and regulating gut microbiota. Animal experiments showed that oral administration of HP-β-CD significantly reduced the Disease Activity Index (DAI) and promoted colon tissue repai

Food Industry: Extending Fruit Shelf Life

An Italian research team developed an edible coating based on Zein and HP-β-CD for strawberry preservation. This coating extended the shelf life of strawberries by 30% at room temperature and reduced the decay index by 60%. HP-β-CD enhances the mechanical and barrier properties of the film by inhibiting protein aggregation

Drug Delivery: Enhancing Bioavailability of Anticancer Agents

Recent studies indicate that HP-β-CD-based nanosponges can significantly increase the loading capacity (19.42%) of hydrophobic anticancer drugs (such as naringenin) and achieve sustained release, with an 8.3-fold improvement in antitumor efficacy compared to free drugs

With its unique "hydrophilic exterior and hydrophobic interior" structure, HP-β-CD demonstrates tremendous potential across multiple fields and is expected to drive innovation in pharmaceuticals, food science, and materials science in the future.